Drag a card by its title · ⚙ to size, swap or remove

The company

Immunome, Inc.

IMNM · Nasdaq

Health CareBiotechnologyNot moving yet

IMNM stood above a rising 150-day average in 42 of the last 52 weekly readings, and has been out of that trend for the last 4 weeks. It is 25.7% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 4
Industry in uptrend: 16% -15 in 4 wk
Insider buys, 12 months: $3.2M
Insider sales, 12 months: $46.7M
Officials’ trades on record: 0
Institutions holding: 195 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.

20 Apr – 19 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months9

Sale orders, 12 months21

Buyers · sellers3 · 7

Who	Did	Shares	Traded
Jack HigginsChief Scientific Officer	sold	13,200at $25.32	11 Sep 2026filed 15 Sep 2026
Isaac BarchasDirector	sold	11,048at $27.25	12 Aug 2026filed 12 Aug 2026
Isaac BarchasDirector	sold	62,291at $26.23	11 Aug 2026filed 12 Aug 2026
Isaac BarchasDirector	sold	10,125at $26.07	10 Aug 2026filed 12 Aug 2026
Isaac BarchasDirector	sold	15,248at $26.06	7 Aug 2026filed 10 Aug 2026
Isaac BarchasDirector	sold	20,840at $26.06	6 Aug 2026filed 10 Aug 2026
Kinney HornCHIEF BUSINESS OFFICER	sold	90,616at $25.09	4 Aug 2026filed 6 Aug 2026
Isaac BarchasDirector	sold	16,906at $24.20	7 Jul 2026filed 7 Jul 2026
Kinney HornCHIEF BUSINESS OFFICER	sold	1,092at $25.00	7 Jul 2026filed 9 Jul 2026
Isaac BarchasDirector	sold	83,094at $24.11	6 Jul 2026filed 7 Jul 2026
Isaac BarchasDirector	sold	75,665at $22.35	2 Jul 2026filed 2 Jul 2026
Isaac BarchasDirector	sold	24,335at $23.33	2 Jul 2026filed 2 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders195+4 on the quarter

New · exited35 · 30

Reported value$2.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
FMR LLCadded · filed 13 Aug 2026	16,987,553$360.0M	+17,599+0.1%
BlackRock, Inc.added · filed 7 Aug 2026	8,805,492$186.6M	+636,818+7.8%
STATE STREET CORPadded · filed 7 Aug 2026	5,494,625$116.4M	+94,724+1.8%
WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 2026	5,210,216$110.4M	+478,239+10.1%
Redmile Group, LLCreduced · filed 14 Aug 2026	4,911,590$104.1M	-647,295−11.6%
PRIMECAP MANAGEMENT COreduced · filed 14 Aug 2026	4,581,431$97.1M	-206,800−4.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,551,289$96.4M	+121,592+2.7%
Driehaus Capital Management LLCadded · filed 14 Aug 2026	4,346,139$92.1M	+246,238+6.0%
ENAVATE SCIENCES GP, LLCunchanged · filed 14 Aug 2026	3,613,799$76.6M	00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	2,754,889$58.4M	+194,225+7.6%